67 related articles for article (PubMed ID: 10827815)
1. Pharmacokinetics of sebacic acid in rats.
Favuzzi AM; Mingrone G; Bertuzzi A; Salinari S; Gandolfi A; Greco AV
Eur Rev Med Pharmacol Sci; 1999; 3(3):119-25. PubMed ID: 10827815
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependent pharmacokinetics of 1-(2-deoxy-beta-D- ribofuranosyl)-2,4-difluoro-5-iodobenzene: a potential mimic of 5-iodo-2'-deoxyuridine.
Khalili P; Naimi E; Sun WY; Knaus EE; Wiebe LI
Biopharm Drug Dispos; 2003 Dec; 24(9):385-95. PubMed ID: 14689467
[TBL] [Abstract][Full Text] [Related]
3. Tracer study of metabolism and tissue distribution of sebacic acid in rats.
Tataranni PA; Mingrone G; De Gaetano A; Raguso C; Greco AV
Ann Nutr Metab; 1992; 36(5-6):296-303. PubMed ID: 1492757
[TBL] [Abstract][Full Text] [Related]
4. Toxicity of disodium sebacate.
Greco AV; Mingrone G; Arcieri Mastromattei E; Finotti E; Castagneto M
Drugs Exp Clin Res; 1990; 16(10):531-6. PubMed ID: 2100736
[TBL] [Abstract][Full Text] [Related]
5. Kinetics and thermogenesis of medium-chain monocarboxylic and dicarboxylic acids in man: sebacate and medium-chain triglycerides.
Mingrone G; Greco AV; Castagneto M; De Gaetano A; Tataranni PA; Raguso C
JPEN J Parenter Enteral Nutr; 1993; 17(3):257-64. PubMed ID: 8505832
[TBL] [Abstract][Full Text] [Related]
6. Single dose pharmacokinetics and bioavailability of glucosamine in the rat.
Aghazadeh-Habashi A; Sattari S; Pasutto F; Jamali F
J Pharm Pharm Sci; 2002; 5(2):181-4. PubMed ID: 12207871
[TBL] [Abstract][Full Text] [Related]
7. [Investigation on pharmacokinetics of helicid in rats].
Chen Z; Jiang XH; Ren J; Liu TM; Ma G; Wang L
Zhongguo Zhong Yao Za Zhi; 2008 Nov; 33(22):2662-6. PubMed ID: 19216167
[TBL] [Abstract][Full Text] [Related]
8. Intravenous pharmacokinetics, oral bioavailability and dose proportionality of ragaglitazar, a novel PPAR-dual activator in rats.
Jagannath K; Chaluvadi MR; Mullangi R; Mamidi NV; Srinivas NR
Biopharm Drug Dispos; 2004 Oct; 25(7):323-8. PubMed ID: 15386480
[TBL] [Abstract][Full Text] [Related]
9. Toxicokinetics of lambda-cyhalothrin in rats.
Anadón A; Martínez M; Martínez MA; Díaz MJ; Martínez-Larrañaga MR
Toxicol Lett; 2006 Aug; 165(1):47-56. PubMed ID: 16513299
[TBL] [Abstract][Full Text] [Related]
10. Dose-linear pharmacokinetics of oleanolic acid after intravenous and oral administration in rats.
Jeong DW; Kim YH; Kim HH; Ji HY; Yoo SD; Choi WR; Lee SM; Han CK; Lee HS
Biopharm Drug Dispos; 2007 Mar; 28(2):51-7. PubMed ID: 17163409
[TBL] [Abstract][Full Text] [Related]
11. Tissue uptake and oxidation of disodium sebacate in man.
Mingrone G; Greco AV; Bertuzzi A; Arcieri-Mastromattei E; Tacchino RM; Marino F; Finotti E; Castagneto M
JPEN J Parenter Enteral Nutr; 1991; 15(4):454-9. PubMed ID: 1910110
[TBL] [Abstract][Full Text] [Related]
12. Metabolic effects and disposition of sebacate, an alternate dicarboxylic fuel substrate.
Greco AV; Mingrone G; Raguso C; Tataranni A; Finotti E; Tacchino RM; Capristo E; De Gaetano A; Castagneto M
Ann Nutr Metab; 1992; 36(1):1-11. PubMed ID: 1590667
[TBL] [Abstract][Full Text] [Related]
13. Absorption and enterohepatic circulation of baicalin in rats.
Xing J; Chen X; Zhong D
Life Sci; 2005 Nov; 78(2):140-6. PubMed ID: 16107266
[TBL] [Abstract][Full Text] [Related]
14. The effect of enzyme inhibitor and absorption site following [D-ala2, D-leu5]enkephalin oral administration in rats.
Lee HJ; Amidon GL
Biopharm Drug Dispos; 2002 May; 23(4):131-41. PubMed ID: 12015787
[TBL] [Abstract][Full Text] [Related]
15. Effect of chronic ethanol administration on disposition of ethanol and its metabolites in rat.
Kozawa S; Yukawa N; Liu J; Shimamoto A; Kakizaki E; Fujimiya T
Alcohol; 2007 Mar; 41(2):87-93. PubMed ID: 17517325
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma.
Xu W; Sun J; Zhang TT; Ma B; Cui SM; Chen DW; He ZG
Acta Pharmacol Sin; 2006 Dec; 27(12):1642-6. PubMed ID: 17112421
[TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
18. Distribution profile of 2,5-dimethoxy-4-bromoamphetamine (DOB) in rats after oral and subcutaneous doses.
Beránková K; Szkutová M; Balíková M
Forensic Sci Int; 2007 Aug; 170(2-3):94-9. PubMed ID: 17629428
[TBL] [Abstract][Full Text] [Related]
19. Low-abundance plasma and urinary [(15)N]urea enrichments analyzed by gas chromatography/combustion/isotope ratio mass spectrometry.
Metges CC; Daenzer M; Petzke KJ; Elsner A
J Mass Spectrom; 2002 May; 37(5):489-94. PubMed ID: 12112754
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
